Low dose CE-MRA

European Journal of Radiology

Volumn 80, Issue 1, 2011, Pages 2-8

  Nael, Kambiz ^a   Moriarty, John M ^a   Finn, J Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contrast enhanced magnetic resonance angiography (CE MRA); Digital subtraction angiography (DSA); Gadolinium dose; Nephrogenic systemic fibrosis (NSF); Time resolved MR angiography (TR MRA)

Indexed keywords

GADOLINIUM;

ARTERIOVENOUS MALFORMATION; CHRONIC KIDNEY DISEASE; CONTRAST ENHANCED MAGNETIC RESONANCE ANGIOGRAPHY; HEART DISEASE; HUMAN; IMAGE QUALITY; MAGNETIC FIELD; MAGNETIC RESONANCE ANGIOGRAPHY; NEPHROGENIC SYSTEMIC FIBROSIS; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RADIATION SAFETY; REVIEW; SENSITIVITY AND SPECIFICITY;

CONTRAST MEDIA; GADOLINIUM; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; NEPHROGENIC FIBROSING DERMOPATHY; RADIATION DOSAGE;

EID: 80052784373     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2011.01.092     Document Type: Review

References (40)

1. E.A. Sadowski, L.K. Bennett, M.R. Chan, A.L. Wentland, A.L. Garrett, and R.W. Garrett Nephrogenic systemic fibrosis: risk factors and incidence estimation Radiology 243 1 2007 148 157 (Pubitemid 46579705)
2. P. Marckmann, L. Skov, K. Rossen, A. Dupont, M.B. Damholt, and J.G. Heaf Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging J Am Soc Nephrol 17 9 2006 2359 2362 (Pubitemid 44300951)
3. S. Clorius, K. Technau, T. Watter, E. Schwertfeger, K.G. Fischer, and G. Walz Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agent Clin Nephrol 68 4 2007 249 252 (Pubitemid 47527447)
4. R. Habibi, M.S. Krishnam, D.G. Lohan, F. Barkhordarian, M. Jalili, and R.S. Saleh High-spatial-resolution lower extremity MR angiography at 3.0 T: contrast agent dose comparison study Radiology 248 2 2008 680 692
5. A. Tomasian, N. Salamon, D.G. Lohan, M. Jalili, J.P. Villablanca, and J.P. Finn Supraaortic arteries: contrast material dose reduction at 3.0-T high-spatial-resolution MR angiography - feasibility study Radiology 249 3 2008 980 990
6. M.A. Perazella, and R.A. Rodby Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease Am J Med 120 7 2007 561 562 (Pubitemid 46977329)
7. T.A. Collidge, P.C. Thomson, P.B. Mark, J.P. Traynor, A.G. Jardine, and S.T. Morris Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort Radiology 245 1 2007 168 175 (Pubitemid 47417800)
8. N.G. Campeau, J. Huston 3rd, M.A. Bernstein, C. Lin, and G.F. Gibbs Magnetic resonance angiography at 3.0 Tesla: initial clinical experience Top Magn Reson Imaging 12 3 2001 183 204 (Pubitemid 32565657)
9. W.A. Willinek, M. Born, B. Simon, H.J. Tschampa, C. Krautmacher, and J. Gieseke Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging - initial experience Radiology 229 3 2003 913 920 (Pubitemid 37467601)
10. K.R. Thulborn Clinical rationale for very-high-field (3.0 Tesla) functional magnetic resonance imaging Top Magn Reson Imaging 10 1 1999 37 50 (Pubitemid 29288712)
11. P.M. Robitaille, A.M. Abduljalil, and A. Kangarlu Ultra high resolution imaging of the human head at 8 Tesla: 2K × 2K for Y2K J Comput Assist Tomogr 24 1 2000 2 8
12. P.A. Rinck, and R.N. Muller Field strength and dose dependence of contrast enhancement by gadolinium-based MR contrast agents Eur Radiol 9 5 1999 998 1004
13. J. Bodurka, P.J. Ledden, P. van Gelderen, R. Chu, J.A. de Zwart, and D. Morris Scalable multichannel MRI data acquisition system Magn Reson Med 51 1 2004 165 171 (Pubitemid 38095714)
14. D.G. King S.B., D. Peterson, S Varosi, and D.A. Molyneaux A Comparison of 1, 4, and 8 channel phased array head coils at 1.5 T 9th Annual Meeting of ISMRM Glasgow, Scotland 2001
15. J.A. de Zwart, P.J. Ledden, P. van Gelderen, J. Bodurka, R. Chu, and J.H. Duyn Signal-to-noise ratio and parallel imaging performance of a 16-channel receive-only brain coil array at 3.0 Tesla Magn Reson Med 51 1 2004 22 26 (Pubitemid 38095698)
16. M.A. Griswold, P.M. Jakob, R.M. Heidemann, M. Nittka, V. Jellus, and J. Wang Generalized autocalibrating partially parallel acquisitions (GRAPPA) Magn Reson Med 47 6 2002 1202 1210 (Pubitemid 34587412)
17. K.P. Pruessmann, M. Weiger, M.B. Scheidegger, and P. Boesiger SENSE: sensitivity encoding for fast MRI Magn Reson Med 42 5 1999 952 962 (Pubitemid 29521486)
18. D.K. Sodickson, and W.J. Manning Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays Magn Reson Med 38 4 1997 591 603 (Pubitemid 27419224)
19. C.E. Hayes, N. Hattes, and P.B. Roemer Volume imaging with MR phased arrays Magn Reson Med 18 2 1991 309 319
20. P.B. Roemer, W.A. Edelstein, C.E. Hayes, S.P. Sousa, and O.M. Mueller The NMR phased array Magn Reson Med 16 2 1990 192 225
21. C.E. Hayes, and P.B. Roemer Noise correlations in data simultaneously acquired from multiple surface coil arrays Magn Reson Med 16 2 1990 181 191
22. C.D. Constantinides, C.R. Westgate, W.G. O'Dell, E.A. Zerhouni, and E.R. McVeigh A phased array coil for human cardiac imaging Magn Reson Med 34 1 1995 92 98
23. Q. Dong, D.R. Hurst, H.J. Weinmann, T.L. Chenevert, F.J. Londy, and M.R. Prince Magnetic resonance angiography with gadomer-17. An animal study original investigation Invest Radiol 33 9 1998 699 708 (Pubitemid 30261968)
24. K. Nael, R. Saleh, G.K. Nyborg, C.G. Fonseca, H.J. Weinmann, and G. Laub Pulmonary MR perfusion at 3.0 Tesla using a blood pool contrast agent: initial results in a swine model J Magn Reson Imaging 25 1 2007 66 72 (Pubitemid 46098860)
25. J.M. Idée, M. Port, C. Medina, E. Lancelot, E. Fayoux, and S. Ballet Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review Toxicology 248 2-3 2008 77 88
26. S.K. Morcos Extracellular gadolinium contrast agents: differences in stability Eur J Radiol 66 2 2008 175 179
27. T. Frenzel, P. Lengsfeld, H. Schirmer, J. Hütter, and H.J. Weinmann Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 °C Invest Radiol 43 12 2008 817 828
28. M.F. Bellin, and A.J. Van Der Molen Extracellular gadolinium-based contrast media: an overview Eur J Radiol 66 2 2008 160 167
29. A.Y. Olukotun, J.R. Parker, M.J. Meeks, M.A. Lucas, D.R. Fowler, and T.R. Lucas Safety of gadoteridol injection: U.S. clinical trial experience J Magn Reson Imaging 5 1 1995 17 25
30. C.U. Herborn, T.C. Lauenstein, S.G. Ruehm, S. Bosk, J.F. Debatin, and M. Goyen Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography Invest Radiol 38 1 2003 27 33 (Pubitemid 36083433)
31. M.D. Morasch, J. Collins, F.S. Pereles, J.C. Carr, M.K. Eskandari, and W.H. Pearce Lower extremity stepping-table magnetic resonance angiography with multilevel contrast timing and segmented contrast infusion J Vasc Surg 37 1 2003 62 71 (Pubitemid 36236945)
32. F.S. Pereles, J.D. Collins, J.C. Carr, C. Francois, M.D. Morasch, and R.M. McCarthy Accuracy of stepping-table lower extremity MR angiography with dual-level bolus timing and separate calf acquisition: hybrid peripheral MR angiography Radiology 240 1 2006 283 290 (Pubitemid 43902620)
33. K. Nael, M. Krishnam, A. Nael, A. Ton, S.G. Ruehm, and J.P. Finn Peripheral contrast-enhanced MR angiography at 3.0 T, improved spatial resolution and low dose contrast: initial clinical experience Eur Radiol 18 12 2008 2893 2900
34. F.R. Korosec, R. Frayne, T.M. Grist, and C.A. Mistretta Time-resolved contrast-enhanced 3D MR angiography Magn Reson Med 36 3 1996 345 351 (Pubitemid 26299259)
35. C. Fink, S. Ley, R. Kroeker, M. Requardt, H.U. Kauczor, and M. Bock Time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the chest: combination of parallel imaging with view sharing (TREAT) Invest Radiol 40 1 2005 40 48 (Pubitemid 40029893)
36. R.P. Lim, M. Shapiro, E.Y. Wang, M. Law, J.S. Babb, and L.E. Rueff 3D time-resolved MR angiography (MRA) of the carotid arteries with time-resolved imaging with stochastic trajectories: comparison with 3D contrast-enhanced bolus-chase MRA and 3D time-of-flight MRA AJNR Am J Neuroradiol 2008
37. Y. Wu, O. Wieben, C.A. Mistretta, and F.R. Korosec Evaluation of temporal and spatial characteristics of 2D HYPR processing using simulations Magn Reson Med 59 5 2008 1090 1098 (Pubitemid 351590523)
38. R. Frayne, T.M. Grist, J.S. Swan, D.C. Peters, F.R. Korosec, and C.A. Mistretta 3D MR DSA: effects of injection protocol and image masking J Magn Reson Imaging 12 3 2000 476 487
39. D.G. Lohan, A. Tomasian, R.S. Saleh, A. Singhal, M.S. Krishnam, and J.P. Finn Ultra-low-dose, time-resolved contrast-enhanced magnetic resonance angiography of the carotid arteries at 3.0 Tesla Invest Radiol 44 4 2009 207 217
40. K. Nael, M. Krishnam, S.G. Ruehm, H.J. Michaely, G. Laub, and J.P. Finn Time-resolved MR angiography in the evaluation of central thoracic venous occlusive disease AJR Am J Roentgenol 192 6 2009 1731 1738